Lower GI Bleed — Initial Assessment and Localization

Key Points

• Hematochezia with shock can still arise from a brisk upper-GI source.
• CTA is the preferred rapid localization test for ongoing hemodynamically significant lower-GI bleeding in many modern pathways.
• Colonoscopy is important but does not have to occur within hours for every admitted LGIB patient.
• A restrictive transfusion strategy is appropriate for most stable patients, with individualized exceptions.
• Do not attribute major anemia to hemorrhoids without excluding a more significant source.
• Active CTA extravasation can lead directly to angiographic embolization.
• Ischemic colitis requires a different treatment pathway from painless diverticular bleeding.
• Anticoagulant resumption should balance recurrent bleeding against thrombosis rather than being stopped indefinitely.

Algorithm

1. Assess hemodynamic severity, ongoing bleeding, abdominal symptoms, medications, and possible upper-GI clues.
2. Obtain IV access, CBC, chemistry, type and screen/crossmatch, and relevant coagulation testing.
3. Resuscitate and transfuse according to physiology and hemoglobin trajectory.
4. Use CTA promptly for ongoing severe hematochezia or instability.
5. Proceed to angiographic embolization when CTA identifies active bleeding and the clinical situation warrants intervention.
6. Perform adequately prepared colonoscopy after stabilization for diagnosis and endoscopic treatment where appropriate.
7. Escalate uncontrolled bleeding to multidisciplinary GI, interventional radiology, and surgical management.
8. Treat the identified cause and arrange cancer screening and antithrombotic follow-up.

Clinical Synopsis & Reasoning

Hematochezia usually indicates a colorectal source but a brisk upper-GI bleed can transit rapidly enough to appear red or maroon, especially with shock, elevated BUN/creatinine ratio, or hematemesis history. Diverticular bleeding is typically painless and can be large-volume. Ischemic colitis often causes abdominal pain followed by bloody diarrhea. Inflammatory or infectious colitis produces diarrhea and systemic symptoms, while hemorrhoidal bleeding is usually small-volume and should not be blamed for major anemia without excluding another source.

Assess vital signs, orthostatic symptoms, perfusion, ongoing stool output, abdominal findings, anticoagulant use, prior colonoscopy, and comorbid cardiovascular disease. Check CBC, metabolic panel, type and screen, and coagulation tests when relevant. Risk scores can support disposition but should not override shock physiology. Digital rectal examination can identify melena, gross blood, masses, or local anorectal pathology. Avoid assuming a stable initial hemoglobin rules out major acute bleeding.

The 2023 ACG lower-GI bleeding guideline gives an expanded role to CT angiography for severe ongoing hematochezia. CTA can rapidly localize active bleeding without bowel preparation and direct transcatheter embolization. In a stable patient after bleeding slows, bowel preparation followed by colonoscopy can identify diverticula, vascular lesions, tumors, colitis, and post-polypectomy sites. Tagged RBC scanning has a more limited contemporary role when CTA is readily available.

Treatment Strategy & Disposition

Resuscitate significant blood loss with IV access, balanced crystalloid judiciously, and blood products according to hemodynamics and hemoglobin. A restrictive transfusion strategy is appropriate for most stable patients, but active shock and significant cardiovascular ischemia require individualized thresholds. Reverse life-threatening anticoagulant-associated hemorrhage according to the specific drug. Avoid routine platelet transfusion for antiplatelet exposure without a clear indication.

For ongoing hemodynamically significant hematochezia, obtain CTA promptly. Active extravasation should trigger interventional radiology consultation for angiography and embolization. Surgical consultation is required for bleeding that cannot be controlled by endoscopic or radiologic therapy, especially when transfusion needs are escalating. Colonoscopy is performed after adequate bowel cleansing once the patient is stable; urgent colonoscopy within a few hours has not consistently improved major outcomes compared with nonemergent inpatient colonoscopy.

Treat the cause after localization. Diverticular bleeding often stops spontaneously but can recur. Ischemic colitis requires bowel rest, fluid optimization, cause-directed treatment, and surgical evaluation for peritonitis, gangrene, or fulminant disease. Colitis management depends on inflammatory versus infectious etiology. Restart necessary antithrombotic therapy after hemostasis according to thrombotic and rebleeding risk. Arrange colorectal cancer evaluation when bleeding is unexplained or age/risk makes malignancy possible.

Epidemiology / Risk Factors

• Diverticular hemorrhage is one of the most common causes of substantial acute lower-GI bleeding in adults.
• Incidence rises with age, diverticulosis, vascular disease, NSAID use, and antithrombotic therapy.
• Angioectasia is more common in older adults and selected cardiac or renal conditions.
• Most episodes stop spontaneously, but recurrence is common in diverticular and angioectatic bleeding.
• Colorectal neoplasia remains an important diagnosis to exclude in unexplained bleeding.

Investigations

Common Etiologies

Pharmacology

Prognosis / Complications

• Most patients survive acute LGIB, but morbidity rises with age, shock, comorbidity, and ongoing transfusion need.
• Embolization can control severe localized bleeding without surgery in many cases.
• Ischemic colitis ranges from transient mucosal injury to gangrene requiring colectomy.
• Recurrent bleeding is common when the underlying vascular or diverticular lesion remains present.
• Timely cancer detection can be a major downstream benefit of appropriate diagnostic follow-up.

Patient Education / Counseling

• Return immediately for recurrent large-volume blood, black stool with weakness, syncope, chest pain, or shortness of breath.
• Avoid nonprescribed NSAIDs after a significant GI bleed unless a clinician specifically approves them.
• Follow bowel-preparation and colonoscopy instructions carefully if outpatient completion is planned.
• Do not stop prescribed anticoagulants or antiplatelet therapy indefinitely without a coordinated plan.
• Report persistent abdominal pain, fever, or bloody diarrhea after an ischemic or inflammatory colitis diagnosis.
• Keep colorectal cancer screening and GI follow-up even if the visible bleeding resolves.

Notes

The 2023 ACG guideline increased the emphasis on CT angiography for severe active lower-GI bleeding and de-emphasized the need for urgent colonoscopy within a fixed early-hour window for every patient.

Source localization should match bleeding behavior. Active severe hemorrhage favors CTA and possible embolization, while stable intermittent bleeding is better suited to prepared colonoscopy.

References

1. ACG Acute Lower Gastrointestinal Bleeding Guideline 2023 — Link
2. American College of Gastroenterology Lower GI Bleeding Resources — Link